Physician profile
Robert A Hanson
NPI 1932328978
$8,786.99
in general payments reported to CMS, 2019-2025
40 companies · $2,315 in 2025
The $2,315 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $346 · 2021: $1,446 · 2022: $874 · 2023: $1,515 · 2024: $1,758 · 2025: $2,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,567 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,567.04 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $1,592.63 | 2023-2025 | Ffrct |
| Abbott Laboratories | $940.27 | 2019-2025 | Cardiomems, Mitraclip, Gallant |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $893.75 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $749.97 | 2020-2025 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Aop Health US, LLC | $538.39 | 2025 | Rapiblyk |
| Novartis Pharmaceuticals Corporation | $477.06 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $441.04 | 2019-2024 | Xarelto |
| Medtronic, INC. | $376.46 | 2021-2025 | Venaseal, Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $304.01 | 2022-2025 | Camzyos, Eliquis |
| Atricure, INC. | $291.97 | 2022-2024 | |
| Esperion Therapeutics, INC. | $231.88 | 2021-2022 | |
| Pfizer INC. | $195.90 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $176.10 | 2021-2024 | Verquvo |
| Baxter Healthcare | $153.86 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $152.18 | 2019-2023 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.